{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["BKCa channel", "SHRs", "benzimidazole", "cGMP", "hypertension", "l-type VDCC"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33859561", "DateRevised": {"Year": "2021", "Month": "04", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "03", "Day": "30"}], "Language": ["eng"], "ELocationID": ["611109", "10.3389/fphar.2021.611109"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "12", "PubDate": {"Year": "2021"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Antihypertensive Effect of a Novel Angiotensin II Receptor Blocker Fluorophenyl Benzimidazole: Contribution of cGMP, Voltage-dependent Calcium Channels, and BK<sub>Ca</sub> Channels to Vasorelaxant Mechanisms.", "Pagination": {"StartPage": "611109", "MedlinePgn": "611109"}, "Abstract": {"AbstractText": ["<b>Background:</b> The current study presents the novel angiotensin II receptor blocker fluorophenyl benzimidazole (FPD) as an antihypertensive agent in the SHR model of hypertension. We investigated the role of cGMP, voltage-dependent L-type calcium channels, and BK<sub>Ca</sub> channels in the vasorelaxant mechanisms of FPD in the rat superior mesenteric artery. <b>Methods:</b> The antihypertensive effect of FPD was examined using an invasive technique measuring blood pressure in SHR animals. Using a myograph, tension measurement was completed in the superior mesenteric artery to elucidate the mechanisms of vasorelaxation involving AT1 receptors, the NO/cGMP pathway, L-type calcium channels, and BK<sub>Ca</sub> channels. Ion flux (Ca<sup>2+</sup>, K<sup>+</sup>) studies were conducted in aortic smooth muscle cells. Putative targets proteins were determined by <i>in silico</i> docking studies. A safety evaluation of FPD was carried out using Swiss albino mice. <b>Results:</b> FPD significantly decreased blood pressure in SHR. It relaxed superior mesenteric arteries in a concentration-dependent manner and significantly inhibited angiotensin II-induced contraction. The relaxation response was also mediated by an increase in tissue cGMP levels, inhibition of L-type calcium channels, and the opening of BK<sub>Ca</sub> channels. FPD further enhanced efflux of K<sup>+</sup> and inhibited Bay K8644-stimulated Ca<sup>2+</sup> influx in aortic smooth muscle cells and docked well in an <i>in silico</i> study with the targets. It was well tolerated in the toxicity study. <b>Conclusion:</b> The present study reports the antihypertensive activity of novel AT-1 receptor blocker FPD at 50 and 100\u00a0mg\u00a0kg<sup>-1</sup> with cGMP, L-type calcium channels, and BK<sub>Ca</sub> channels as putative targets of vasorelaxation, and was found safe in oral toxicity."], "CopyrightInformation": "Copyright \u00a9 2021 Iqbal, Verma, Yadav, Alam, Shafiq, Mishra, Khan, Hanif, Negi and Chanda."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India."}], "LastName": "Iqbal", "ForeName": "Hina", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Phytochemistry Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India."}], "LastName": "Verma", "ForeName": "Amit Kumar", "Initials": "AK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India."}], "LastName": "Yadav", "ForeName": "Pankaj", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Biology Lab, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India."}], "LastName": "Alam", "ForeName": "Sarfaraz", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, India."}], "LastName": "Shafiq", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India."}], "LastName": "Mishra", "ForeName": "Divya", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Biology Lab, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India."}], "LastName": "Khan", "ForeName": "Feroz", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, India."}], "LastName": "Hanif", "ForeName": "Kashif", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Phytochemistry Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India."}], "LastName": "Negi", "ForeName": "Arvind Singh", "Initials": "AS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India."}], "LastName": "Chanda", "ForeName": "Debabrata", "Initials": "D"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Alam S., Khan F. (2019). 3D-QSAR, Docking, ADME/Tox studies on Flavone analogs reveal anticancer activity through Tankyrase inhibition. Sci. Rep. 9 (1), 5414. 10.1038/s41598-019-41984-7", "ArticleIdList": ["10.1038/s41598-019-41984-7", "PMC6443786", "30932078"]}, {"Citation": "Alam S., Khan F. (2018). QSAR, docking, ADMET, and system pharmacology studies on tormentic acid derivatives for anticancer activity. J. Biomol. Struct. Dyn. 36 (9), 2373\u20132390. 10.1080/07391102.2017.1355846", "ArticleIdList": ["10.1080/07391102.2017.1355846", "28705120"]}, {"Citation": "Alam S., Nasreen S., Ahmad A., Darokar M. P., Khan F. (2020). Detection of natural inhibitors against human liver cancer cell lines through QSAR, Molecular Docking, and ADMET studies. Curr. Top. Med. Chem. 20, 1. 10.2174/1568026620666201204155830", "ArticleIdList": ["10.2174/1568026620666201204155830", "33280598"]}, {"Citation": "Alonso M. J., Rico I., Salaices M., Marin J. (1989). Effects of the Ca agonists Bay K 8644 and CGP 28392 on vascular smooth muscle tone. Gen. Pharmacol. 20, 827\u2013831. 10.1016/0306-3623(89)90338-8", "ArticleIdList": ["10.1016/0306-3623(89)90338-8", "2480266"]}, {"Citation": "Ball C. J., Wilson D. P., Turner S. P., Saint D. A., Beltrame J. F. (2009). Heterogeneity of L- and T-channels in the vasculature: rationale for the efficacy of combined L- and T-blockade. Hypertension 53 (4), 654\u2013660. 10.1161/HYPERTENSIONAHA.108.125831", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.108.125831", "19237682"]}, {"Citation": "Bansal Y., Silakari O. (2012). The therapeutic journey of benzimidazoles: a review. Bioorg. Med. Chem. 20, 6208\u20136236. 10.1016/j.bmc.2012.09.013", "ArticleIdList": ["10.1016/j.bmc.2012.09.013", "23031649"]}, {"Citation": "Chanda D., Prieto-Lloret J., Singh A., Iqbal H., Yadav P., Snetkov V., et al. (2016). Glabridin-induced vasorelaxation: evidence for a role of BKca channels and cyclic GMP. Life Sci. 165, 26\u201334. 10.1016/j.lfs.2016.09.018", "ArticleIdList": ["10.1016/j.lfs.2016.09.018", "PMC5101995", "27686831"]}, {"Citation": "Chanda D., Shanker K., Pal A., Luqman S., Bawankule D. U., Mani D., et al. (2009). Safety evaluation of trikatu, a generic ayurvedic medicine in charles foster rats. J. Toxicol. Sci. 34, 99\u2013108. 10.2131/jts.34.99", "ArticleIdList": ["10.2131/jts.34.99", "19182439"]}, {"Citation": "Chaturvedi A. K., Verma A. K., Thakur J. P., Roy S., Bhushan Tripathi S., Kumar B. S., et al. (2018). A novel synthesis of 2-arylbenzimidazoles in molecular sieves-MeOH system and their antitubercular activity. Bioorg. Med. Chem. 26 (15), 4551\u20134559. 10.1016/j.bmc.2018.07.049", "ArticleIdList": ["10.1016/j.bmc.2018.07.049", "30097361"]}, {"Citation": "Cheng Y. Q., Tan B. Y., Yu X. H., Dong W. Z., Su D. F., Zhu D. Q., et al. (2018). Synergism of amlodipine and candesartan on blood pressure reduction and organ protection in hypertensive rats. Clin. Exp. Pharmacol. Physiol. 45 (6), 514\u2013524. 10.1111/1440-1681.12901", "ArticleIdList": ["10.1111/1440-1681.12901", "29193272"]}, {"Citation": "Choisy S. C., Kim S. J., Hancox J. C., Jones S. A., James A. F. (2015). Effects of candesartan, an angiotensin II receptor type I blocker, on atrial remodeling in spontaneously hypertensive rats. Physiol. Rep. 3 (1), e12274. 10.14814/phy2.12274", "ArticleIdList": ["10.14814/phy2.12274", "PMC4387744", "25626873"]}, {"Citation": "Das A., Gangarde Y. M., Tomar V., Shinde O., Upadhyay T., Alam S., et al. (2020). Small-molecule inhibitor prevents insulin fibrillogenesis and preserves activity. Mol. Pharm. 17 (6), 1827\u20131834. 10.1021/acs.molpharmaceut.9b01080", "ArticleIdList": ["10.1021/acs.molpharmaceut.9b01080", "32347728"]}, {"Citation": "Ernst M. E., Kelly M. W. (1998). Mibefradil, a pharmacologically distinct calcium antagonist. Pharmacotherapy 18 (3), 463\u2013485. 10.1002/j.1875-9114.1998.tb03110.x", "ArticleIdList": ["10.1002/j.1875-9114.1998.tb03110.x", "9620098"]}, {"Citation": "Estrada-Soto S., Villalobos-Molina R., Aguirre-Crespo F., Vergara-Galicia J., Moreno-D\u00edaz H., Torres-Piedra M., et al. (2006). Relaxant activity of 2-(substituted phenyl)-1H-benzimidazoles on isolated rat aortic rings: design and synthesis of 5-nitro derivatives. Life Sci. 79 (5), 430\u2013435. 10.1016/j.lfs.2006.01.019", "ArticleIdList": ["10.1016/j.lfs.2006.01.019", "16487544"]}, {"Citation": "Jain M., Iqbal H., Yadav P., Singh H., Chanda D., Jagavelu K., et al. (2020). Autophagy inhibition by chloroquine prevents increase in blood pressure & preserves endothelial functions. Trop. J. Pharm. Res. 19, 789\u2013796. 10.4314/tjpr.v19i4.16", "ArticleIdList": ["10.4314/tjpr.v19i4.16"]}, {"Citation": "Jugdutt B. I., Xu Y., Balghith M., Moudgil R., Menon V. (2000). Cardioprotection induced by AT1R blockade after reperfused myocardial infarction: association with regional increase in AT2R, IP3R and PKCepsilon proteins and cGMP. J. Cardiovasc. Pharmacol. Ther. 5 (4), 301\u2013311. 10.1054/JCPT.2000.19245", "ArticleIdList": ["10.1054/JCPT.2000.19245", "11150400"]}, {"Citation": "Khan M. T., Razi M. T., Jan S. U., Mukhtiar M., Gul R., Hussain A., et al. (2018). Synthesis, characterization and antihypertensive activity of 2-phenyl substituted benzimidazoles. Pak. J. Pharm. Sci. 31, 1067\u20131074. 10.17582/journal.pjar/2018/31.4.390.395", "ArticleIdList": ["10.17582/journal.pjar/2018/31.4.390.395", "29731445"]}, {"Citation": "Liu T., Schroeder H. J., Zhang M., Wilson S. M., Terry M. H., Longo L. D., et al. (2016). S-nitrosothiols dilate the mesenteric artery more potently than the femoral artery by a cGMP and L-type calcium channel-dependent mechanism. Nitric Oxide 58, 20\u201327. 10.1016/j.niox.2016.05.006", "ArticleIdList": ["10.1016/j.niox.2016.05.006", "PMC6322392", "27235767"]}, {"Citation": "Lloyd J., Finlay H. J., Atwal K., Kover A., Prol J., Yan L., et al. (2009). Dihydropyrazolopyrimidines containing benzimidazoles as K(V)1.5 potassium channel antagonists. Bioorg. Med. Chem. Lett. 19, 5469\u20135473. 10.1016/j.bmcl.2009.07.083", "ArticleIdList": ["10.1016/j.bmcl.2009.07.083", "19665893"]}, {"Citation": "Mao S., Li C. (2015). Hypotensive and angiotensin-converting enzyme inhibitory activities of Eisenia fetida extract in spontaneously hypertensive rats. Evid. Based Complement. Altern. Med. 2015, 349721. 10.1155/2015/349721", "ArticleIdList": ["10.1155/2015/349721", "PMC4700176", "26798397"]}, {"Citation": "Nagai M., Horikoshi K., Izumi T., Seki S., Taniguchi M., Taniguchi I., et al. (2004). Cardioprotective action of perindopril versus candesartan in renovascular hypertensive rats. Cardiovasc. Drugs Ther. 18 (5), 353\u2013362. 10.1007/s10557-005-5059-7", "ArticleIdList": ["10.1007/s10557-005-5059-7", "15717137"]}, {"Citation": "Prieto-Lloret J., Snetkov V. A., Shaifta Y., Docio I., Connolly M. J., MacKay C. E., et al. (2018). Role of reactive oxygen species and sulfide-quinone oxoreductase in hydrogen sulfide-induced contraction of rat pulmonary arteries. Am. J. Physiol. Lung Cell Mol. Physiol. 314 (4), L670\u2013L685. 10.1152/ajplung.00283.2016", "ArticleIdList": ["10.1152/ajplung.00283.2016", "PMC5966778", "29351439"]}, {"Citation": "Rizzoni D., Porteri E., Bettoni G., Piccoli A., Castellano M., Muiesan M. L., et al. (1998). Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 32 (5), 798\u2013806. 10.1097/00005344-199811000-00017", "ArticleIdList": ["10.1097/00005344-199811000-00017", "9821855"]}, {"Citation": "Shah D. I., Sharma M., Bansal Y., Bansal G., Singh M. (2008). Angiotensin II\u2014AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives. Eur. J. Med. Chem. 43 (9), 1808\u20131812. 10.1016/j.ejmech.2007.11.008", "ArticleIdList": ["10.1016/j.ejmech.2007.11.008", "18158200"]}, {"Citation": "Singh A., Kumar B. S., Iqbal H., Alam S., Yadav P., Verma A. K., et al. (2019). Antihypertensive activity of diethyl-4,4\u2032-dihydroxy-8,3\u2032-neolign-7,7\u2032-dien-9,9\u2032-dionate: a continuation study in L-NAME treated wistar rats. Eur. J. Pharmacol. 858, 172482. 10.1016/j.ejphar.2019.172482", "ArticleIdList": ["10.1016/j.ejphar.2019.172482", "31233749"]}, {"Citation": "Singh A., Kumar B. S., Alam S., Iqbal H., Khan M. F., Negi A. S., et al. (2017). Diethyl-4,4\u2032-dihydroxy-8,3\u2032-neolign-7,7\u2032-dien-9,9\u2032-dionate exhibits antihypertensive activity in rats through increase in intracellular cGMP level and blockade of calcium channels. Eur. J. Pharmacol. 799, 84\u201393. 10.1016/j.ejphar.2017.01.044", "ArticleIdList": ["10.1016/j.ejphar.2017.01.044", "28159537"]}, {"Citation": "Varming T., Christophersen P., M\u00f8ller A., Peters D., Axelsson O., Nielsen E. \u00d8. (1996). Synthesis and biological activity of the neuronal calcium channel blocker 2-amino-1-(2,5-dimethoxyphenyl)-5-trifluoromethyl benzimidazole (NS-649). Bioorg. Med. Chem. Lett. 6, 245\u2013248. 10.1016/0960-894x(96)00010-8", "ArticleIdList": ["10.1016/0960-894x(96)00010-8"]}, {"Citation": "Weber S. C., Gratopp A., Akanbi S., Rheinlaender C., Sallmon H., Barikbin P., et al. (2011). Isolation and culture of fibroblasts, vascular smooth muscle, and endothelial cells from the fetal rat ductus arteriosus. Pediatr. Res. 70, 236\u2013241. 10.1203/PDR.0b013e318225f748", "ArticleIdList": ["10.1203/PDR.0b013e318225f748", "21629157"]}, {"Citation": "WHO (2017). WHO fact sheets: cardiovascular diseases. Geneva, Switzerland: WHO."}, {"Citation": "Woolley D. W. (1944). Some biological effects produced by benzimidazole& their reversal by purines. J. Biol. Chem. 152, 225\u2013232. 10.1016/s0021-9258(18)72045-0", "ArticleIdList": ["10.1016/s0021-9258(18)72045-0"]}, {"Citation": "Wu Z., Anh N. T. P., Yan Y. J., Xia M. B., Wang Y. H., Qiu Y., et al. (2019). Design, synthesis and biological evaluation of AT1 receptor blockers derived from 6-substituted aminocarbonylbenzimidazoles. Eur. J. Med. Chem. 181, 111553. 10.1016/j.ejmech.2019.07.056", "ArticleIdList": ["10.1016/j.ejmech.2019.07.056", "31369932"]}, {"Citation": "Zhu W., Da Y., Wu D., Zheng H., Zhu L., Wang L., et al. (2014). Design, synthesis and biological evaluation of new 5-nitro benzimidazole derivatives as AT1 antagonists with anti-hypertension activities. Bioorg. Med. Chem. 22 (7), 2294\u20132302. 10.1016/j.bmc.2014.02.008", "ArticleIdList": ["10.1016/j.bmc.2014.02.008", "24613628"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "9", "Day": "28"}, {"Year": "2021", "Month": "2", "Day": "9"}, {"Year": "2021", "Month": "4", "Day": "16", "Hour": "6", "Minute": "34"}, {"Year": "2021", "Month": "4", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "17", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "3", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["33859561", "PMC8042648", "10.3389/fphar.2021.611109", "611109"]}}], "PubmedBookArticle": []}